| Financial Year |
March 31 2023 |
| Monetary Funds |
1,209,542,871.00 |
| Held-for-trading Financial Assets |
9,100,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
749,581,176.66 |
| Advances to Suppliers |
57,516,964.00 |
| Other Receivables |
687,956,576.15 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
578,159,811.54 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
234,088,779.74 |
| Total Current Assets |
3,701,002,863.83 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
239,210,000.00 |
| Long-term Equity Investment |
173,072,660.76 |
| Investment Properties |
-- |
| Fixed Assetes |
1,377,654,131.24 |
| Under-construction Projects |
282,192,290.50 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
391,641,434.90 |
| R&D expenses |
252,567,593.52 |
| Goodwill |
4,378,099.09 |
| Long-Term Deferred and Prepaid Expenses |
25,492,549.10 |
| Deferred Income Tax Assets |
426,506,994.98 |
| Other Non-Current Assets |
51,246,862.51 |
| Sub-Total of Non-Current Assets |
3,354,298,290.83 |
| Total Assets |
7,055,301,154.66 |
| Short-Term Loans |
1,551,861,193.90 |
| Trading Financial liabilities |
-- |
| Notes Payable |
8,392,527.80 |
| Accounts Payable |
345,863,381.61 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
104,532,736.01 |
| Taxes Payable |
19,784,881.64 |
| Interest Payable |
-- |
| Dividend Payable |
1,270,308.27 |
| Other payables |
267,894,048.88 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
719,720,644.03 |
| Other Current Liabilities |
21,217,207.23 |
| Sub-Total of Current Liabilities |
3,200,147,119.93 |
| Long-term Loans |
404,891,140.72 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
81,001,478.58 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
9,379,593.63 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
645,247,606.69 |
| Total Liabilities |
3,845,394,726.62 |
| Paid-In Capital(Or Share Stock) |
1,087,588,486.00 |
| Capital Surplus |
514,773,564.68 |
| Surplus Reserve |
12,836,903.17 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,445,340,507.65 |
| Minority Stockholder's Interest |
129,393,102.86 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,080,513,325.18 |
| Owner's Equity（Stockholder's Equity） |
3,209,906,428.04 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,055,301,154.66 |
